Anti-RKIP antibody [EPR2875Y]
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
5
(5 Reviews)
|
(25 Publications)
Rabbit Recombinant Monoclonal RKIP antibody. Suitable for IHC-P, WB, ICC/IF, Flow Cyt (Intra) and reacts with Mouse, Rat, Human samples. Cited in 25 publications.
View Alternative Names
PBP, PEBP, PEBP1, Phosphatidylethanolamine-binding protein 1, PEBP-1, HCNPpp, Neuropolypeptide h3, Prostatic-binding protein, Raf kinase inhibitor protein, RKIP
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RKIP antibody [EPR2875Y] (AB76582)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human ovarian carcinoma tissue sections labeling RKIP with purified ab76582 at 1/500 dilution (0.26 μg/ml). Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer, pH 9.0). ImmunoHistoProbe one step HRP Polymer (ready to use) was used as the secondary antibody. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-RKIP antibody [EPR2875Y] (AB76582)
Intracellular Flow Cytometry analysis of HeLa (human cervix adenocarcinoma) cells labeling RKIP (red) with purified ab76582 at a 1/20 dilution. Cells were fixed with 4% paraformaldehyde and permeabilized with 90% methanol. A goat anti-rabbit IgG (Alexa Fluorr® 488) (ab150077) was used as the secondary antibody at a 1/2000 dilution. Black - Rabbit monoclonal IgG (ab172730). Blue (unlabeled control) - Cells without incubation with the primary and secondary antibodies.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RKIP antibody [EPR2875Y] (AB76582)
Staining of formalin-fixed, paraffin-embedded human brain tissue using 1/250 ab76582 (unpurified).
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-RKIP antibody [EPR2875Y] (AB76582)
Immunocytochemistry/ Immunofluorescence analysis of HepG2 (Human hepatocellular carcinoma epithelial cell) cells labeling RKIP with purified ab76582 at 1 : 50 dilution (2.6 µg/ml). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1 : 200 (2.5 µg/ml). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) was used as the secondary antibody at 1 : 1000 (2 µg/ml) dilution. DAPI (blue) was used as nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RKIP antibody [EPR2875Y] (AB76582)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of rat testis tissue sections labeling RKIP with purified ab76582 at 1/500 dilution (0.26 μg/ml). Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer, pH 9.0). ImmunoHistoProbe one step HRP Polymer (ready to use) was used as the secondary antibody. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RKIP antibody [EPR2875Y] (AB76582)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of mouse kidney tissue sections labeling RKIP with purified ab76582 at 1/500 dilution (0.26 μg/ml). Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer, pH 9.0). ImmunoHistoProbe one step HRP Polymer (ready to use) was used as the secondary antibody. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.
- WB
Lab
Western blot - Anti-RKIP antibody [EPR2875Y] (AB76582)
All lanes:
Western blot - Anti-RKIP antibody [EPR2875Y] (ab76582) at 1/1000 dilution
Lane 1:
HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysates at 20 µg
Lane 2:
A549 (Human lung carcinoma epithelial cell) whole cell lysates at 20 µg
Lane 3:
Mouse brain lysates at 20 µg
Lane 4:
Mouse testis lysates at 20 µg
Lane 5:
Rat brain lysates at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 21 kDa
Observed band size: 21 kDa
false
- WB
Unknown
Western blot - Anti-RKIP antibody [EPR2875Y] (AB76582)
All lanes:
Western blot - Anti-RKIP antibody [EPR2875Y] (ab76582) at 1/5000 dilution
Lane 1:
HeLa cell lysate at 10 µg
Lane 2:
A549 cell lysate at 10 µg
Lane 3:
HepG2 cell lysate at 10 µg
Lane 4:
A431 cell lysate at 10 µg
Secondary
All lanes:
goat anti-rabbit HRP at 1/2000 dilution
Predicted band size: 21 kDa
Observed band size: 21 kDa
false
- WB
Unknown
Western blot - Anti-RKIP antibody [EPR2875Y] (AB76582)
All lanes:
Western blot - Anti-RKIP antibody [EPR2875Y] (ab76582) at 1/5000 dilution
All lanes:
Western blot - Recombinant Human RKIP protein (Tag Free) (<a href='/en-us/products/proteins-peptides/recombinant-human-rkip-protein-ab87892'>ab87892</a>) at 0.1 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-preadsorbed-ab97080'>ab97080</a>) at 1/5000 dilution
Predicted band size: 21 kDa
true
Exposure time: 30s
Related conjugates and formulations (9)
-
Anti-RKIP antibody [EPR2875Y] - BSA and Azide free
-
660 APC
APC Anti-RKIP antibody [EPR2875Y]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-RKIP antibody [EPR2875Y]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-RKIP antibody [EPR2875Y]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-RKIP antibody [EPR2875Y]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-RKIP antibody [EPR2875Y]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-RKIP antibody [EPR2875Y]
-
HRP Anti-RKIP antibody [EPR2875Y]
-
578 PE
PE Anti-RKIP antibody [EPR2875Y]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
RKIP interacts with multiple signaling pathways by acting as a suppressor of the mitogen-activated protein kinase (MAPK) pathway. It also plays roles in modulating the signaling of nuclear factor kappa B (NF-κB) and G-protein coupled receptor kinase (GRK) pathways. As part of these pathways RKIP contributes to the regulation of cell proliferation differentiation and apoptosis making it an important player in maintaining cellular homeostasis.
Pathways
RKIP's role centers on the RAF/MEK/ERK and NF-κB signaling pathways. Within the RAF/MEK/ERK pathway RKIP modulates cellular responses by controlling the activation of Raf-1 influencing cell growth and division. In the NF-κB pathway RKIP inhibits phosphorylation of IKK thereby impacting inflammatory responses which links RKIP to proteins like MEK and ERK as well as IKK.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (25)
Recent publications for all applications. Explore the full list and refine your search
Bioengineering & translational medicine 10:e70025 PubMed41030280
2025
Applications
Unspecified application
Species
Unspecified reactive species
eLife 13: PubMed39878441
2025
Applications
Unspecified application
Species
Unspecified reactive species
Lipids in health and disease 23:128 PubMed38685023
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 14:1179742 PubMed37622116
2023
Applications
Unspecified application
Species
Unspecified reactive species
CNS neuroscience & therapeutics 29:2972-2985 PubMed37287422
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular medicine 51: PubMed36382638
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cardiovascular medicine 9:875434 PubMed36017103
2022
Applications
Unspecified application
Species
Unspecified reactive species
BioMed research international 2022:8077058 PubMed35757465
2022
Applications
Unspecified application
Species
Unspecified reactive species
Proceedings of the National Academy of Sciences of the United States of America 119:e2121867119 PubMed35696587
2022
Applications
Unspecified application
Species
Unspecified reactive species
Neuropsychiatric disease and treatment 17:1001-1019 PubMed33854318
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com